Novel Mutations of TCTN3/LTBP2 with Cellular Function Changes in Congenital Heart Disease Associated with Polydactyly
Congenital heart disease (CHD) associated with polydactyly involves various genes. We aimed to identify variations from genes related to complex CHD with polydactyly and to investigate the cellular functions related to the mutations. Blood was collected from a complex CHD case with polydactyly and whole exome sequencing (WES) was performed. The CRISPR/Cas9 system was used to generate human pluripotent stem cell with mutations (hPSCs-Mut) that were differentiated into cardiomyocytes (hPSC-CMs-Mut) and analyzed by transcriptomics on day 0, 9, and 13. Two heterozygous mutations, LTBP2 (c.2206G>A) and TCTN3 (c.1268G>A) were identified via WES but no TBX5 mutations were found. The stable cell lines of hPSCs-LTBP2mu/TCTN3mu were constructed and differentiated into hPSC-CMs-LTBP2mu/TCTN3mu. Compared to the wild type, LTBP2 mutation delayed the development of CMs. The TCTN3 mutation consistently presented lower rate and weaker force of the contraction of CMs. For gene expression pattern of persistent up-regulation, pathways in cardiac development and congenital heart disease were enriched in hPSCs-CM-LTBP2mu, compared with hPSCs-CM-WT. Thus, the heterozygous mutations in TCTN3 and LTBP2 affect contractility (rate and force) of cardiac myocytes and may affect the development of the heart. These findings provide new insights into the pathogenesis of complex CHD with polydactyly.